as of 02-06-2026 11:43am EST
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | MOUNTAIN VIEW |
| Market Cap: | 25.6M | IPO Year: | 1996 |
| Target Price: | N/A | AVG Volume (30 days): | 150.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.78 - $1.70 | Next Earning Date: | 03-26-2026 |
| Revenue: | $50,647,000 | Revenue Growth: | 4.58% |
| Revenue Growth (this year): | 9.61% | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -3988000.0 | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Chief Financial Officer
Avg Cost/Share
$1.38
Shares
2,500
Total Value
$3,450.00
Owned After
115,190
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$1.44
Shares
1,101
Total Value
$1,587.64
Owned After
115,190
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$1.46
Shares
1,300
Total Value
$1,898.00
Owned After
115,190
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$1.48
Shares
3,385
Total Value
$5,009.46
Owned After
115,190
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$1.52
Shares
1,243
Total Value
$1,889.36
Owned After
115,190
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$1.48
Shares
5,221
Total Value
$7,716.12
Owned After
115,190
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$1.51
Shares
2,159
Total Value
$3,233.27
Owned After
115,190
Chief Financial Officer
Avg Cost/Share
$1.50
Shares
2,100
Total Value
$3,147.27
Owned After
115,190
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$1.42
Shares
3,496
Total Value
$5,006.31
Owned After
115,190
Director
Avg Cost/Share
$1.01
Shares
2,000
Total Value
$2,019.80
Owned After
251,550
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Dizon Romeo R | IRIX | Chief Financial Officer | Feb 3, 2026 | Buy | $1.38 | 2,500 | $3,450.00 | 115,190 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Jan 29, 2026 | Buy | $1.44 | 1,101 | $1,587.64 | 115,190 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Jan 28, 2026 | Buy | $1.46 | 1,300 | $1,898.00 | 115,190 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Jan 27, 2026 | Buy | $1.48 | 3,385 | $5,009.46 | 115,190 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Jan 26, 2026 | Buy | $1.52 | 1,243 | $1,889.36 | 115,190 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Jan 23, 2026 | Buy | $1.48 | 5,221 | $7,716.12 | 115,190 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Jan 21, 2026 | Buy | $1.51 | 2,159 | $3,233.27 | 115,190 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Jan 20, 2026 | Buy | $1.50 | 2,100 | $3,147.27 | 115,190 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Jan 16, 2026 | Buy | $1.42 | 3,496 | $5,006.31 | 115,190 | |
| MOORE WILLIAM M | IRIX | Director | Dec 16, 2025 | Buy | $1.01 | 2,000 | $2,019.80 | 251,550 |
IRIX Breaking Stock News: Dive into IRIX Ticker-Specific Updates for Smart Investing
See how IRIX stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "IRIX IRIDEX Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.